aTyr Pharma Inc.

NASDAQ: LIFE · Real-Time Price · USD
1.90
0.05 (2.70%)
At close: Jun 04, 2024, 10:00 PM

aTyr Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
n/a -50.39M -45.34M -33.78M
Depreciation & Amortization
n/a 2.74M 1.7M 1.3M
Stock-Based Compensation
n/a 2.6M 2.15M 1.61M
Other Working Capital
n/a 2.7M -7.57M -4.24M
Other Non-Cash Items
n/a n/a 441K 366K
Deferred Income Tax
n/a n/a n/a 6K
Change in Working Capital
n/a 15.01M -833K -2.59M
Operating Cash Flow
n/a -33.22M -41.89M -33.08M
Capital Expenditures
n/a -4.21M -1.64M -192K
Cash Acquisitions
n/a 15K 179K 50K
Purchase of Investments
n/a -106.98M -42.12M -126.51M
Sales Maturities Of Investments
n/a 91.05M 90.83M 35.08M
Other Investing Acitivies
17.23M n/a 48.89M -91.37M
Investing Cash Flow
17.23M -20.13M 47.24M -91.57M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a 105K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
39.86M 66.23M 5.45M 110.03M
Financial Cash Flow
39.86M 66.23M 5.45M 110.03M
Net Cash Flow
n/a 12.88M 10.81M -14.62M
Free Cash Flow
n/a -37.44M -43.53M -33.27M